Product NDC: | 0069-0469 |
Proprietary Name: | CHANTIX |
Non Proprietary Name: | varenicline tartrate |
Active Ingredient(s): | 1 mg/1 & nbsp; varenicline tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0469 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021928 |
Marketing Category: | NDA |
Start Marketing Date: | 20060510 |
Package NDC: | 0069-0469-12 |
Package Description: | 2 BLISTER PACK in 1 CARTON (0069-0469-12) > 28 TABLET, FILM COATED in 1 BLISTER PACK (0069-0469-11) |
NDC Code | 0069-0469-12 |
Proprietary Name | CHANTIX |
Package Description | 2 BLISTER PACK in 1 CARTON (0069-0469-12) > 28 TABLET, FILM COATED in 1 BLISTER PACK (0069-0469-11) |
Product NDC | 0069-0469 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | varenicline tartrate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20060510 |
Marketing Category Name | NDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | VARENICLINE TARTRATE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Partial Cholinergic Nicotinic Agonist [EPC],Partial Cholinergic Nicotinic Agonists [MoA] |